Symbol Technologies Introduces Premium In-Counter Mini-Slot Scanner for Retail Environments
Geschrieben am 03-10-2006 |
Holtsville, New York (ots/PRNewswire) -
- LS7808 Offers Superior Performance for Enhanced Customer Service
Symbol Technologies, Inc. (NYSE: SBL), The Enterprise Mobility Company(TM), today introduced a new in-counter mini-slot scanner for increased productivity in high-traffic retail environments. Incorporating omni-directional scanning to eliminate the need to orient the bar code for faster and more accurate read rates on even the most poorly printed bar codes, the LS7808 scanner can help improve customer service with reduced checkout times.
(Logo: http://www.newscom.com/cgi-bin/prnh/20041029/SYMBOLOGO )
"Symbol has been designing, selling and supporting bar code scanners for more than 30 years and was a pioneering developer of Visible Laser Diode (VLD) based horizontal mini-slot scanners," said Bob Sanders, vice president and general manager of Symbol's advanced data capture division. "The new LS7808 scanner builds on this rich heritage with advanced technologies that enable cashiers to focus on customers instead of the products being scanned."
Designed for the most demanding retail environments, the high-performance LS7808 offers hands-free scanning for fast and accurate read rates, with minimal cashier effort. The LS7808 provides intuitive, productivity-enhancing functionality that allows novice and advanced users alike to move customers quickly through checkout and increase customer satisfaction rates at the retail point-of-sale. Symbol's advanced software algorithms allow customers using the LS7808 scanner to quickly and accurately scan one-dimensional (1D) bar codes including those that are damaged, small or poorly printed to help improve operational efficiencies.
For additional productivity, Symbol customers can connect a secondary handheld scanner to the LS7808 for flexibility in scanning large and oversized items at checkout without having to lift them from the shopping cart. With its sleek design to save space on the countertop, the new LS7808 scanner is also available with scratch-proof glass and a stainless steel encasement to prevent scanner damage -- especially in grocery and home improvement environments where continued exposure to cans and other hard metal items can potentially damage a system.
To help customers protect their investment and maintain peak performance, Symbol Global Services offers Service from the Start with Comprehensive Coverage for the LS7808. This unique service goes far beyond normal wear and tear to include accidental damage to exit windows, scan elements and more at no additional charge -- virtually eliminating unforeseen repair expenses. On-site options are also available for maximum response with minimum service interruption.
The Symbol LS7808 mini-slot scanner is currently available to order globally through Symbol partners.
About Symbol Technologies
Symbol Technologies, Inc., The Enterprise Mobility Company(TM), is a recognized worldwide leader in enterprise mobility, delivering products and solutions that capture, move and manage information in real time to and from the point of business activity. Symbol enterprise mobility solutions integrate advanced data capture products, radio frequency identification technology, mobile computing platforms, wireless infrastructure, mobility software and world-class services programs under the Symbol Enterprise Mobility Services brand. Symbol enterprise mobility products and solutions are proven to increase workforce productivity, reduce operating costs, drive operational efficiencies and realize competitive advantages for the world's leading companies. More information is available at http://www.symbol.com.
For Symbol Technologies: For media information: Traci Hoch Betsy Blicharz Symbol Technologies, Inc. Edelman Public Relations +1-631-738-5426 +1-212-704-4484 traci.hoch@symbol.com elizabeth.blicharz@edelman.com For financial information: For industry analyst information: Lori Chaitman Shirley Schroedl Symbol Technologies, Inc. Symbol Technologies, Inc. +1-631-738-5050 +1-631-738-4823 lori.chaitman@symbol.com shirley.schroedl@symbol.com
Web site: http://www.symbol.com
ots Originaltext: Symbol Technologies, Inc. Im Internet recherchierbar: http://www.presseportal.de
Contact: For media information: Betsy Blicharz of Edelman Public Relations, +1-212-704-4484, elizabeth.blicharz@edelman.com, for Symbol Technologies; or Traci Hoch, +1-631-738-5426, traci.hoch@symbol.com, or for financial information: Lori Chaitman, +1-631-738-5050, lori.chaitman@symbol.com, or for industry analyst information: Shirley Schroedl, +1-631-738-4823, shirley.schroedl@symbol.com, all of Symbol Technologies, Inc. Photo: http://www.newscom.com/cgi-bin/prnh/20041029/SYMBOLOGO
Kontaktinformationen:
Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.
Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.
Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.
http://www.bankkaufmann.com/topics.html
Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.
@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf
E-Mail: media(at)at-symbol.de
32702
weitere Artikel:
- MacroChem beginnt Phase II-Versuchsreihe mit lokal antimykotischem EcoNail(TM)-Lack Wellesley Hills, Massachusettes (ots/PRNewswire) - MacroChem Corporation (OTC- Bulletin Board: MACM) hat mit der Aufnahme von Patienten mit Onychomykose, einer Pilzinfektion der Finger- und Fussnägel, zu einer Phase II-Versuchsreihe von EcoNail(TM) begonnen. MacroChem geht davon aus, etwa 40 Patienten in dieser multizentrischen Open-Label-Versuchsreihe in den USA aufzunehmen. Patienten, die an der Versuchsreihe teilnehmen, welche unter dem US-amerikanischen IND-Status von MacroChem durchgeführt wird, werden 48 Wochen lang behandelt und Wirksamkeitsbeurteilungen mehr...
- Oncalis AG und ChemDiv Inc. gehen umfassende, weitreichende Partnerschaft ein Zürich, Schweiz und San Diego (ots/PRNewswire) - Oncalis AG aus Schlieren in der Schweiz und ChemDiv Inc. aus San Diego geben eine weitreichende Zusammenarbeit in Forschung und Entwicklung bekannt. Oncalis wird seine firmeneigene, auf Hefezellen basierende Technologie einsetzen und biologische Assays entwickeln und ChemDiv wird medizinchemische und biologische in vitro und in vivo Dienstleistungen erbringen, um Kandidaten für Rezeptor-Tyrosine-Kinase-Inhibitoren und andere krebsbezogene Zielmoleküle zu entwickeln. Oncalis AG ist kürzlich mehr...
- Isotechnika Receives European Patent for Lead Immunosuppressive Drug, ISA247 Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the Company has been issued European Patent No. EP0991660 for its lead immunosuppressive drug, ISA247. The patent entitled "DEUTERATED AND UNDEUTERATED CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS" is the ninth patent to be issued internationally in this patent family. Patents relating to these claims have issued in the following countries; Australia (No. 750245, issued July 11, 2002 and No. 774744 issued October 21, 2004), Canada (No. 2,298,572 mehr...
- Norsemont Reports 1.23 Billion Pounds of Copper as Inferred Resources Plus 749 Million Pounds as Indicated Resources With Significant Molybdenum and Silver at the Constancia Project Vancouver, Canada (ots/PRNewswire) - - CONFERENCE CALL AT 11.00AM (PT), OCTOBER 4, 2006 - TSX-V: NOM Norsemont Mining Inc. ("Norsemont" or "the Company") (TSX-V: NOM; Frankfurt: N8S; WKN: A0DQKK; OTC-BB: NOMFF; ISIN: CA6565291045) is pleased to announce results of an Initial Resource Estimate on the Constancia Copper-Molybdenum-Silver Porphyry Project in southern Peru. An independent mineral resource estimate has been completed on the Constancia and San Jose Zones of the Constancia Project in Southern Peru. The report estimates mehr...
- Xenomics liefert Business-Update in WallStreetReporter Interview New York (ots/PRNewswire) - - CEO über proprietäre DNA-Technologie, Produktentwicklungsinitiativen und neue Vorstandsmitglieder Xenomics, Inc. (OTC Bulletin Board: XNOM; FWB:XE7), die Quelle der nächsten Generation von medizinischen DNA-Tests, gab kürzlich im Rahmen eines Interviews mit WallStreetReporter ein umfassendes Business-Update. Dr. David Tomei, CEO und einer der Gründer von Xenomics, sprach über die proprietäre DNA-Diagnosetechnologie, Produktentwicklungsinitiativen und über Dr. David Sidransky, ein neues Mitglied im Board mehr...
|
|
|
Mehr zu dem Thema Aktuelle Wirtschaftsnews
Der meistgelesene Artikel zu dem Thema:
DBV löst Berechtigungsscheine von knapp 344 Mio. EUR ein
durchschnittliche Punktzahl: 0 Stimmen: 0
|